Kalvista Pharmaceuticals Inc reports results for the quarter ended October 31 - Earnings Summary

Kalvista Pharmaceuticals

05/12/2024 14:32

* Kalvista Pharmaceuticals Inc  KALV.OQ  reported a
quarterly
adjusted loss of 91 cents​​ per share for the quarter ended
October 31, lower than the same quarter last year, when the
company reported EPS of -80 cents.  The mean expectation of
six analysts for the quarter was for a loss of 91 cents per
share. Wall Street expected results to range from -94 cents
to -85 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Kalvista Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 91 cents​.
    * The company reported a quarterly loss of $42.27 million.
    * Kalvista Pharmaceuticals Inc shares had fallen by 18.3%
this
quarter and lost 22.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Kalvista
Pharmaceuticals Inc is $31.50 
This summary was machine generated from LSEG data December 5 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Oct. 31 2024      -0.91          -0.91          Met
 Jul. 31 2024      -0.91          -0.87          Beat
 Apr. 30 2024      -0.73          -1.02          Missed
 Jan. 31 2024      -0.77          -0.84          Missed